Schubert & Co’s GSK GSK Stock Holding History

Schubert & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-196	Closed	-$6.97K	–	653
2023 Q1	$6.97K	Buy	196 +72	+58%	+$2.52K	0.01%	333
2022 Q4	$4.36K	Sell	124 -113	-48%	-$3.76K	﹤0.01%	492
2022 Q3	$7K	Sell	237 -1	-0.4%	-$38	0.01%	277
2022 Q2	$13K	Buy	+238	New	+$13.1K	0.01%	144

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schubert & Co's GSK Position: Q2 2023 in Review

Schubert & Co sold out of GSK (GSK) in Q2 2023, closing a stake of 196 shares — an estimated $6.97K sold.

Schubert & Co first reported a position in GSK in Q2 2022 and held it in 4 quarters. The position peaked at $13K in Q2 2022. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Schubert & Co reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 196 GSK shares in Q2 2023, an estimated $6.97K.
Schubert & Co first reported a position in GSK in Q2 2022 and held it in 4 quarters.
Schubert & Co's GSK position peaked at $13K in Q2 2022.
827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.